Cartilage Regeneration Potential in Early Osteoarthritis of the Knee: A Prospective, Randomized, Open, and Blinded...

Area of Science:

• Orthopedics
• Regenerative Medicine
• Biotechnology

Background:

• Early-stage knee osteoarthritis (OA) presents a significant clinical challenge due to the lack of effective regenerative treatments.
• Current therapeutic options offer limited cartilage repair capabilities.

Purpose of the Study:

• To compare the cartilage regenerative potential, clinical effectiveness, and safety of intra-articular injections of autologous adipose-derived mesenchymal stem cells (ADSCs) against hyaluronic acid (HA) in patients with early knee OA.

Main Methods:

• A prospective, open-blinded, multi-center study involving 48 patients with early knee OA.
• Participants were randomized to receive either ADSC or HA intra-articular injections.
• Primary outcome measures included MRI-assessed cartilage lesion volume, ultrasound-measured synovial thickness, and WOMAC scores over a 6-month period.

Main Results:

• ADSC injections demonstrated significant, progressive cartilage regeneration, evidenced by a decrease in medial femoral cartilage lesion volume.
• The ADSC group showed a significant reduction in synovial thickness at 3 and 6 months post-injection.
• Both groups experienced symptom relief, but the ADSC group exhibited superior and sustained improvements in WOMAC pain, stiffness, and function scores.

Conclusions:

• Intra-articular ADSC injections offer superior cartilage restoration on MRI compared to HA injections for early knee OA.
• ADSCs provide better clinical outcomes and symptom management than HA, establishing them as a promising regenerative therapy.
• No serious adverse events were reported, indicating a favorable safety profile for ADSC treatment.